Roles of the NKG2D immunoreceptor and its ligands

Nature Reviews Immunology

Volumn 3, Issue 10, 2003, Pages 781-790

  Raulet, David H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; LYMPHOCYTE RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN SPECIFICITY; CELL STIMULATION; CELL TRANSFORMATION; GENE; GENE LOCATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; MACROPHAGE ACTIVATION; MOLECULAR RECOGNITION; MOUSE; NATURAL KILLER CELL; NKG2D GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE ACTIVATION; TARGET CELL;

EID: 0142197631     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1199     Document Type: Review

References (76)

1. Houchins, J. P., Yabe, T., McSherry, C., Miyokawa, N. & Bach, F. H. Isolation and characterization of NK cell or NK/T cell-specific CDNA clones. J. Mol. Cell. Immunol. 4, 295-306 (1990).
2. Houchins, J. P., Yabe, T., McSherry, C. & Bach, F. H. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J. Exp. Med. 173, 1017-1020 (1991).
3. Braud, V. M., Allan, D. S. & McMichael, A. J. Functions of nonclassical MHC and non-MHC-encoded class I molecules. Curr. Opin. Immunol. 11, 100-108 (1999).
4. Brown, M. G. et al. A 2-MB YAC contig and physical map of the natural killer gene complex on mouse chromosome 6. Genomics 42, 16-25 (1997).
5. Yabe, T. et al. A multigene family on human chromosome 12 encodes natural killer-cell lectins. Immunogenetics 37, 455-460 (1993).
6. + T cells. In addition, they show that blockade of NKG2D markedly reduces killing of various tumour-cell targets by NK cells.
7. Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N. & Raulet, D. H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nature Immunol. 1, 119-126 (2000). Identification and characterization of ligands for mouse NKG2D (see also reference 15).
8. Sutherland, C. L. et al. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells J. Immunol. 168, 671-679 (2002).
9. Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-729 (1999). This paper identifies human NKG2D as a receptor for MHC class-I-chain-related protein A (MICA) and MICB, and shows that target cells that express NKG2D ligands stimulate NK cells and intestinal epithelial γδ T-cell lines.
10. + αβ cells by NKG2D via engagement by MIC induced on virus-infected cells. Nature Immunol. 2, 255-260 (2001).
11. Roberts, A. I. et al. NKG2D receptors induced by IL-15 co-stimulate CD28-negative effector CTL in the tissue microenvironment. J. Immunol. 167, 5527-5530 (2001).
12. Pende, D. et al. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur. J. Immunol. 31, 1076-1086 (2001).
13. Groh, V., Bruhl, A., El-Gabarawy, H., Nelson, J. L. & Spies, T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 100, 9452-9457 (2003).
14. Kasahara, M., Watanabe, Y., Sumasu, M. & Nagata, T. A family of MHC class I-like genes located in the vicinity of the mouse leukocyte receptor complex. Proc. Natl Acad. Sci. USA 99, 13687-13692 (2002).
15. Cerwenka, A. et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12, 721-727 (2000).
16. Nomura, M., Takihara, Y. & Shimada, K. Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: one of the early inducible clones encodes a novel protein sharing several highly homologous regions with a Drosophila polyhomeotic protein. Differentiation 57, 39-50 (1994).
17. Nomura, M. et al. Genomic structures and characterization of Real family members encoding GPI-anchored cell surface proteins and expressed predominantly in embryonic mouse brain. J. Biochem. 120, 987-995 (1996).
18. Zou, Z., Nomura, M., Takihara, Y., Yasunaga, T. & Shimada, K. Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: a novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules. J. Biochem. 119, 319-328 (1996).
19. Malarkannan, S. et al. The molecular and functional characterization of a dominant minor H antigen, H60. J. Immunol. 161, 3501-3509 (1998).
20. Carayannopoulos, L. N., Naidenko, O. V., Fremont, D. H. & Yokoyama, W. M. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J. Immunol. 169, 4079-4083 (2002).
21. Diefenbach, A., Hsia, J. K., Hsiung, M. Y. & Raulet, D. H. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur. J. Immunol. 33, 381-391 (2003).
22. Cosman, D. et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor Immunity 14, 123-133 (2001). This paper reports the first identification of the UL16-binding proteins (ULBPs), based on their binding to human cytomegalovirus (HCMV)-encoded UL16 protein, and shows that ULBPs bind and trigger NKG2D, resulting in cytokine production and killing by NK cells.
23. Radosavljevic, M. et al. A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. Genomics 79, 114-123 (2002).
24. Steinle, A. et al. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics 53, 279-287 (2001).
25. Onda, H. et al. A novel secreted tumor antigen with a glycosylphosphatidylinositol-anchored structure ubiquitously expressed in human cancers. Biochem. Biophys. Res. Commun. 285, 235-243 (2001).
26. Chalupny, N. J., Sutherland, C. L., Lawrence, W. A., Rein-Weston, A. & Cosman, D. ULBP4 is a novel ligand for human NKG2D. Biochem. Biophys. Res. Commun. 305, 129-135 (2003).
27. Bahram, S., Bresnahan, M., Geraghty, D. E. & Spies, T. A second lineage of mammalian major histocompatibility complex class I genes. Pros. Natl Acad. Sci. USA 91, 6259-6263 (1994).
28. Groh, V. et al. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Pros. Natl Acad. Sci. USA 93, 12445-12450 (1996).
29. Li, P. W. et al. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nature Immunol. 2, 443-451 (2001).
30. O'Callaghan, C. A., Cerwenka, A., Willcox, B. E., Lanier, L. L. & Bjorkman, P. J. Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60 Immunity 15, 201-211 (2001).
31. Carayannopoulos, L. N. et al. Ligands for murine NKG2D display heterogeneous binding behavior. Eur. J. Immunol. 32, 597-605 (2002).
32. Li, P. et al. Crystal structure of the MHC class I homolog MIC-A, a γδ T cell ligand. Immunity 10, 577-584 (1999).
33. Radaev, S., Rostro, B., Brooks, A. G., Colonna, M. & Sun, P. D. Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3. Immunity 15, 1039-1049 (2001).
34. Li, P., McDermott, G. & Strong, R. K. Crystal structures of RAE-1β and its complex with the activating immunoreceptor NKG2D. Immunity 16, 77-86 (2002).
35. Wolan, D. W. et al. Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 Å. Nature Immunol. 2, 248-254 (2001).
36. McFarland, B. J., Kortemme, T., Yu, S. F., Baker, D. & Strong, R. K. Symmetry recognizing asymmetry. Analysis of the interactions between the C-type lectin-like immunoreceptor NKG2D and MHC class I-like ligands. Structure (Camb) 11, 411-422 (2003).
37. Groh, V. et al. Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB. Proc. Natl Acad. Sci. USA 96, 6879-6884 (1999).
38. Jinushi, M. et al. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int. J. Cancer 104, 354-361 (2003).
39. Jinushi, M. et al. Critical role of MHC class I-related chain A and B expression on IFN-α-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J. Immunol. 170, 1249-1256 (2003).
40. Girardi, M. et al. Regulation of cutaneous malignancy by γδ T cells. Science 294, 605-609 (2001).
41. Pende, D. et al. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity Cancer Res. 62, 6178-6186 (2002).
42. Diefenbach, A. & Raulet, D. H. Strategies for target cell recognition by natural killer cells. Immunol. Rev. 181, 170-184 (2001).
43. Welte, S. A. et al. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur. J. Immunol. 33, 194-203 (2003).
44. Tieng, V. et al. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc. Natl Acad. Sci. USA 99, 2977-2982 (2002).
45. Das, H. et al. MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function. Immunity 15, 83-93 (2001).
46. Lodoen, M. et al. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 197, 1245-1253 (2003).
47. Janeway, C. A. Jr & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197-216 (2002).
48. Moretta, L. et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19, 197-223 (2001).
49. Kubin, M. et al. ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells. Eur. J. Immunol. 31, 1428-1437 (2001).
50. Billadeau, D. D., Upshaw, J. L., Schoon, R. A., Dick, C. J. & Leibson, P. J. NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. Nature Immunol. 4, 557-564 (2003). This paper shows that NKG2D-DAP10-dependent cytotoxicity by human NK cells is independent of SYK or ζ-chain-associated protein 70 kDa (ZAP70), and documents the participation of phosphatidylinositol 3-kinase, SH2-domain-containing leukocyte protein of 76 kDa (SLP76), VAV1, RHO-RAC family GTPases and phospholipase C-γ2 as signalling intermediates.
51. Luhder, F. et al. Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists. J. Exp. Med. 197, 955-966 (2003).
52. + T cells, and that these tumour cells Induce long-lasting T-cell-mediated immunity to rechallenge with the parental cell lines that lack expression of NKG2D ligands.
53. Groh, V., Steinle, A., Bauer, S. & Spies, T. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science 279, 1737-1740 (1998).
54. Dechanet, J. et al. Implication of γδ T cells in the human immune response to cytomegalovirus. J. Clin. Invest 103, 1437-1449 (1999).
55. Wu, J. et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285, 730-732 (1999).
56. Chang, C. et al. KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties. J. Immunol. 163, 4652-4654 (1999).
57. Diefenbach, A. et al. Selective associations with signaling molecules determines stimulatory versus co-stimulatory activity of NKG2D Nature Immunol 3, 1142-1149 (2002). This paper shows that alternative splicing gives rise to two isoforms of mouse NKG2D, one of which associates only with DAP10 and the other with DAP12 and DAP10, and shows that DAP12 signalling is required for NKG2D-induced interferon-γ production and optimal cytolysis by NK cells.
58. Gilfillan, S., Ho, E. L., Cella, M., Yokoyama, W. M. & Colona, M. NKG2D recruits two distinct adapters to trigger natural killer cell activation and co-stimulation. Nature Immunol. 3, 1150-1155 (2002). This paper shows that NK cells from DAP10-deficient mice retain cytolytic activity against several tumour-cell targets, indicating that NKG2D signalling is not solely mediated by DAP10. Furthermore, DAP10-deficient mice can still reject RMAS cells that are transfected with retinoic acid early transcript 1γ (Rae1γ).
59. Bukowski, J. F., Biron, C. A. & Welsh, R. M. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus. J. Immunol. 131, 991-996 (1983).
60. Glas, R. et al. Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype: an adaptive component of NK cell-mediated responses. J. Exp. Med. 191, 129-138 (2000).
61. Talmadge, J. E., Meyers, K. M., Prieur, D. J. & Starkey, J. R. Role of natural killer cells in tumor growth and metastasis: C57BL/6 normal and beige mice. J. Natl Cancer Inst. 65, 929-935 (1980).
62. Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J. & Schreiber, R. D. Cancer immunoediting: from immunosurveillance to tumor escape. Nature Immunol. 3, 991-998 (2002).
63. Zompi, S. et al. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nature Immunol. 4, 565-572 (2003).
64. Wu, J., Cherwinski, H., Spies, Phillips, J. H. & Lanier, L. L. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J. Exp. Med. 192, 1059-1067 (2000).
65. Wu, J., Groh, V. & Spies, T. T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial γδ T cells. J Immunol. 169, 1236-1240 (2002).
66. Cerwenka, A., Baron, J. L. & Lanier, L. L. Ectopic expression of retinoic acid early inducible-1 gene (Rae-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor In vivo. Proc. Natl Acad. Sci. USA 98, 11521-11526 (2001). This paper shows that RMA tumour cells that are transfected with NKG2D ligands are rejected in vivo by NK cells in syngeneic mice.
67. Groh, V., Wu, J., Yee, C. & Spies, T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419, 734-738 (2002).
68. Salih, H. R. et al. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood 102, 1389-1396 (2003).
69. Hayakawa, Y. et al. Tumor rejection mediated by NKG2D receptor-ligand interaction is strictly dependent on perforin. J. Immunol. 169, 5377-5381 (2002).
70. + T cells and NK cells in vivo. Nature immunol. 3, 529-535 (2002).
71. Wu, J. et al. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein. J. Immunol. 170, 4196-4200 (2003).
72. Dunn, C. et al. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J. Exp. Med. 197, 1427-1439 (2003).
73. Vales-Gomez, M., Browne, H. & Reyburn, H. T. Expression of the UL16 glycoprotein of human cytomegalovirus protects the virus-infected cell from attack by natural killer cells. BMC Immunol. 4, 4 (2003).
74. Ogasawara, K. et al. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 18, 41-51 (2003).
75. Biragyn, A. et al. Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 298, 1025-1029 (2002).
76. Leadbetter, E. A. et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors, Nature 416, 603-607 (2002).